
Here’s what we know about booster shots for Moderna’s and J&J’s COVID-19 vaccines
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
BALTIMORE, MD, March 6, 2025 – Even though the future of TikTok in the U.S. hangs in the balance, a groundbreaking study in the INFORMS journal Marketing Science introduces a game-changing algorithm that predicts which TikTok ads will drive sales before they even go live.
Contentious minerals deal has sparked a war of words between Trump and Zelensky, and could be announced later this week
Americans have probably heard the word “tariffs” more in the past month than in the past four years — and for good reason. Tariffs are central to President Donald Trump’s economic playbook, despite opposition from mainstream economists and trade experts.
An audio journey of how data and analytics save lives, save money and solve problems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
Explore our resources for multiple topics including:
Millions of people who got Moderna’s or Johnson & Johnson’s COVID-19 vaccines are expected to soon be lining up for another dose.
Step into one of Maryum Al-Hammami’s Southern California toy stores called The Game Chest, and you'll find the experience is as important as a purchase.
The supply chain disruption is shorthand for problems from factory closures to workers who are not working anymore.
New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).
Commercial brokers have always crunched data to make sure an investment makes financial sense. But high-tech analytics can take that analysis to a new level.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today MagazineAnalytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine